LONG-ACTING FORMULATIONS OF INSULINS

Vodena farmaceutska formulacija koja sadrži 300 U/ml glargin insulina, što je ekvimolarno sa 300 IU humanog insulina.Prijava sadrži još 23 patentna zahteva. The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insul...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TERTSCH, KATRIN DR, WERNER, ULRICH DR, LOOS, PETRA DR, BODERKE, PETER DR, FUERST, CHRISTIANE DR, HAHN, ANNKE DR, BECKER, REINHARD DR, SCHOETTLE, ISABELL, MUELLER, WERNER DR
Format: Patent
Sprache:eng ; srp
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Vodena farmaceutska formulacija koja sadrži 300 U/ml glargin insulina, što je ekvimolarno sa 300 IU humanog insulina.Prijava sadrži još 23 patentna zahteva. The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.